계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Cradle Genomics
company
About
Cradle Genomics is a creator of a novel prenatal testing methodology
- 1 - 10
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $17.10M
- Industries
- Biotechnology
- Founded date
- Jan 1, 2018
- Number Of Employee
- 1 - 10
- Operating Status
- Active
At Cradle Genomics, their mission is to provide knowledge that helps every pregnancy. They're dedicated to the transformation of non-invasive prenatal testing (NIPT) by offering the most comprehensive fetal genetic analysis and pregnancy health screening solutions at the earliest stages of pregnancy.Cradle Genomics is newly formed with their headquarters based in San Diego and additional R&D operations located in Detroit. Cradle tests are based on the genetic analysis of fetal cells that are quickly collected during a first trimester visit with no risk to the mother or developing fetus.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$17.10M
Cradle Genomics has raised a total of
$17.10M
in funding over 2 rounds. Their latest funding was raised on
Jul 16, 2019 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 16, 2019 | Series A | $17.10M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Cradle Genomics is funded by 2 investors.
Axon Ventures
and Listwin Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Axon Ventures
|
— | Series A |
|
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
